30-Oct-2026 07:59:52
LAURUSLABSExpansion
KOTAK ON LAURUS LABS ; SELL | TP ₹1,400
• Kotak maintains Sell rating on Laurus Labs with a target price of ₹1,400. • Expects EBITDA CAGR of approximately 34% over FY26–29, with EBITDA margins reaching around 36% by FY29. • Company plans capex of over ₹3,000 crore during FY27–28, largely targeting high-growth projects. • Peptides, oligonucleotides and advanced therapies expected to expand CDMO growth opportunities. • Despite strong earnings growth prospects and CDMO expansion, expensive valuations remain a key concern.
LAURUS LABS LIMITED